These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17186852)

  • 21. Phase I dose escalating study of oral cyclophosphamide in tumour-bearing cats.
    Chan CM; Rassnick KM; Frimberger AE; Nguyen SM; Moore AS
    Vet J; 2020 Apr; 258():105450. PubMed ID: 32564869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary study of the specific endothelin a receptor antagonist zibotentan in combination with docetaxel in patients with metastatic castration-resistant prostate cancer.
    Trump DL; Payne H; Miller K; de Bono JS; Stephenson J; Burris HA; Nathan F; Taboada M; Morris T; Hubner A
    Prostate; 2011 Sep; 71(12):1264-75. PubMed ID: 21271613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093).
    Kuppens IE; Bosch TM; van Maanen MJ; Rosing H; Fitzpatrick A; Beijnen JH; Schellens JH
    Cancer Chemother Pharmacol; 2005 Jan; 55(1):72-8. PubMed ID: 15316750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A.
    Malingré MM; Beijnen JH; Rosing H; Koopman FJ; van Tellingen O; Duchin K; Ten Bokkel Huinink WW; Swart M; Lieverst J; Schellens JH
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):347-54. PubMed ID: 11345652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
    Thomas SM; Ogagan MJ; Freilino ML; Strychor S; Walsh DR; Gooding WE; Grandis JR; Zamboni WC
    Mol Pharmacol; 2008 Mar; 73(3):627-38. PubMed ID: 18025070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancer.
    Dandamudi UB; Adams LM; Johnson B; Bauman J; Morris S; Murray S; Webb RT; Gartner E; Hohl R; Lewis LD
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):783-90. PubMed ID: 20556613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors.
    LoRusso PM; Infante JR; Kim KB; Burris HA; Curt G; Emeribe U; Clemett D; Tomkinson HK; Cohen RB
    BMC Cancer; 2017 Mar; 17(1):173. PubMed ID: 28264648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I study of intravenously administered ATI-1123, a liposomal docetaxel formulation in patients with advanced solid tumors.
    Mahalingam D; Nemunaitis JJ; Malik L; Sarantopoulos J; Weitman S; Sankhala K; Hart J; Kousba A; Gallegos NS; Anderson G; Charles J; Rogers JM; Senzer NN; Mita AC
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1241-50. PubMed ID: 25304209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymeric nanoparticle-docetaxel for the treatment of advanced solid tumors: phase I clinical trial and preclinical data from an orthotopic pancreatic cancer model.
    Song SY; Kim KP; Jeong SY; Park J; Park J; Jung J; Chung HK; Lee SW; Seo MH; Lee JS; Jung KH; Choi EK
    Oncotarget; 2016 Nov; 7(47):77348-77357. PubMed ID: 27764799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical efficacy and safety following dose tapering of ciclosporin in cats with hypersensitivity dermatitis.
    Roberts ES; Tapp T; Trimmer A; Roycroft L; King S
    J Feline Med Surg; 2016 Nov; 18(11):898-905. PubMed ID: 26316515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of oral cyclosporin A when co-administered to enhance the oral absorption of paclitaxel.
    Malingré MM; Ten Bokkel Huinink WW; Duchin K; Schellens JH; Beijnen JH
    Anticancer Drugs; 2001 Aug; 12(7):591-3. PubMed ID: 11487715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot study of oral metformin in cancer-bearing cats.
    Wypij JM
    Vet Comp Oncol; 2017 Jun; 15(2):345-354. PubMed ID: 26490666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours.
    de Jonge MJ; Dumez H; Kitzen JJ; Beuselinck B; Verweij J; Courtney R; Battista A; Brega N; Schöffski P
    Eur J Cancer; 2011 Jun; 47(9):1328-35. PubMed ID: 21439816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I and pharmacokinetic study of lapatinib and docetaxel in patients with advanced cancer.
    LoRusso PM; Jones SF; Koch KM; Arya N; Fleming RA; Loftiss J; Pandite L; Gadgeel S; Weber BL; Burris HA
    J Clin Oncol; 2008 Jun; 26(18):3051-6. PubMed ID: 18565892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual anti-cancer effects of weekly intraperitoneal docetaxel in treatment of advanced gastric cancer patients with peritoneal carcinomatosis: a feasibility and pharmacokinetic study.
    Fushida S; Kinoshita J; Yagi Y; Funaki H; Kinami S; Ninomiya I; Fujimura T; Nishimura G; Kayahara M; Ohta T
    Oncol Rep; 2008 May; 19(5):1305-10. PubMed ID: 18425392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer.
    James J; Murry DJ; Treston AM; Storniolo AM; Sledge GW; Sidor C; Miller KD
    Invest New Drugs; 2007 Feb; 25(1):41-8. PubMed ID: 16969706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir.
    de Weger VA; Stuurman FE; Hendrikx JJMA; Moes JJ; Sawicki E; Huitema ADR; Nuijen B; Thijssen B; Rosing H; Keessen M; Mergui-Roelvink M; Beijnen JH; Schellens JHM; Marchetti S
    Eur J Cancer; 2017 Nov; 86():217-225. PubMed ID: 29031170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of oral cyclosporin to treat feline dermatoses: a retrospective analysis of 23 cases.
    Vercelli A; Raviri G; Cornegliani L
    Vet Dermatol; 2006 Jun; 17(3):201-6. PubMed ID: 16674736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor, tissue, and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenografts.
    Zamboni WC; Strychor S; Joseph E; Parise RA; Egorin MJ; Eiseman JL
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):417-26. PubMed ID: 17957368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metronomic chemotherapy in veterinary patients with cancer: rethinking the targets and strategies of chemotherapy.
    Biller B
    Vet Clin North Am Small Anim Pract; 2014 Sep; 44(5):817-29. PubMed ID: 25174901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.